Dr. Andrew Kolodny, Co-Director, OPRC

Andrew Kolodny, MD, is a Senior Scientist at the Institute for Behavioral Health at the Heller School at Brandeis University and Co-Director of the Opioid Policy Research Collaborative. His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the executive director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics. Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national nonprofit addiction treatment agency and as Chair of Psychiatry at Maimonides Medical Center in New York City. He began his career working for the New York City Department of Health and Mental Hygiene in the Office of the Executive Deputy Commissioner, where he helped develop and implement multiple programs, including city-wide buprenorphine programs, naloxone overdose prevention programs and emergency room screening, brief intervention and referral to treatment (SBIRT) programs for drug and alcohol misuse.

Peter Kreiner, PhD, Co-Director, OPRC

Peter Kreiner, PhD, is a Senior Scientist at the Institute for Behavioral Health at the Heller School at Brandeis University and Co-Director of the Opioid Policy Research Collaborative. He is Principal Investigator for the Prescription Drug Monitoring Program Training and Technical Assistance Center, and for the Prescription Behavior Surveillance System at Brandeis, a longitudinal multi-state database of prescription drug monitoring program data to serve as an early warning surveillance tool and a tool to help evaluate changes in state policy and regulations. Dr. Kreiner has more than 25 years’ experience conducting research and evaluation of substance abuse prevention and treatment systems and programs at community, state, and regional levels. His research interests include small geographic area measures and models, specifically focused on rates of fatal and non-fatal opioid overdose cases, and measures of appropriate and inappropriate prescribing; and network analysis applied to interorganizational networks and provider-patient networks related to care coordination.